Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
5,580
NCT02577627
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
Phase: N/A
Role: Lead Sponsor
Start: Sep 30, 2015
Completion: Sep 30, 2019
NCT02581228
Multi-Centre, Retrospective, Open Label Study, to Validate ML-PrediCare by Patients With Melanoma Under 1st and 2nd Lines of Immunotherapy
Start: Oct 31, 2015
Completion: Nov 30, 2018
NCT06504472
A Randomized Triple-Blind Placebo-Controlled Study to Evaluate the Effects of a Supplement on Lower Urinary Tract Symptoms in Men.
Start: Feb 7, 2024
Completion: Jun 24, 2024